Co-diagnostics, Inc. insider trading

Every open-market purchase and sale by Co-diagnostics, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No open-market insider trades reported in the last five years.

Does following Co-diagnostics, Inc.’s insiders pay?

From April 10, 2018 to September 22, 2021, 6 insiders reported 1 open-market purchase and 12 sales not made under a pre-set plan in Co-diagnostics, Inc. After sales, the shares moved −53.5% against the index over 12 months (a negative figure means selling was the right call).

Co-diagnostics, Inc.: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Durenard Eugene	Director	0	—	—	4	−59.2% (4)	September 22, 2021
Serbin Richard S	Director	0	—	—	3	−60.1% (3)	January 15, 2021
Benson Reed L	General Counsel	0	—	—	2	−37.9% (2)	May 21, 2021
Egan Dwight H	Chief Executive Officer	0	—	—	2	−49.8% (2)	January 20, 2021
Nelson James B	Director	0	—	—	1	−50.4% (1)	January 15, 2021
Satterfield Brent	Chief Science Officer	1	—	—	0	—	April 10, 2018

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded Co-diagnostics, Inc.

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Co-diagnostics, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 1 selling crowd, −28.5%. One company's history is too short to judge by; the test across every company is the better guide.

Month	Crowd	3 months on, vs S&P 500	6 months	12 months
December 31, 2020	4 selling	−7.9%	−28.5%	−32.7%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

← Back to Co-diagnostics, Inc. · Funds · Politicians